Golimumab (Simponi)

golimumab · Centocor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Golimumab (Simponi), covering 2009-07-13 to 2009-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]